Datasets:
sruthiselvakumar
/
dataset

Dataset card Data Studio Files
xet
 Community
text
stringlengths
0
146
Leukemia (CLL) RAI Stage
1 or 2. CLL RAI stage 0 or
lower is excluded.
Neuroendocrine
Tumours
All Neuroendocrine
tumours histologically
classified as T1N0M0
(TNM Classification)
Gastro-Intestinal Stromal
Tumours
All Gastro-Intestinal
Stromal tumours
histologically classified as
Stage I or IA according to
the latest edition of the
AJCC Cancer Staging
Manual which are treated
with surgery or
chemotherapy as
recommended by an
oncologist.
Bone Marrow
Malignancies
All bone marrow
malignancies which do not
require recurrent blood
transfusions,
chemotherapy, targeted
cancer therapies, bone
marrow transplant,
haematopoietic stem cell
Intermediate Stage
diagnosed upon the basis
of a microscopic
examination of fixed
tissues additionally
supported by a biopsy of
the removed organ.
Early prostate cancer that
is histologically described
using the TNM
Classification as T1N0M0
or Prostate cancers
described using another
equivalent classification is
also covered if it has been
treated with a radical
prostatectomy.
The actual undergoing of
the surgeries listed above
and the surgery must be
certified to be absolutely
necessary by an
oncologist Partial surgical
removal such as
lumpectomy and partial
mastectomy and partial
prostatectomy are
specifically excluded.
Carcinoma in situ means
the focal autonomous new
growth of carcinomatous
cells confined to the cells
in which it originated and
has not yet resulted in the
invasion and/ or
destruction of surrounding
tissues. ‘Invasion’ means
an infiltration and/or active
destruction of normal
tissue beyond the
basement membrane. The
diagnosis of the
Carcinoma in situ must
always be supported by a
histopathological report.
The following conditions
are specifically excluded
from the coverage:
• Clinical diagnosis
• Any diagnosis on the
basis of finding tumour
cells and/or tumorassociated molecules in
blood, saliva, faeces,
urine or any other bodily
fluid in the absence of
further definitive and
clinically verifiable
evidence does not meet
the above definition.
• Any lesion or tumour
which is histologically
Advanced Stage1
A) All tumours which are
histologically classified as
any of the following:
• Pre-malignant;